Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes-Reference-Cited by-同舟云学术

Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes

Published:2014-06-12 Issue:9 Volume:42 Page:1379-1391
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Zhang J. George,Ho Thuy,Callendrello Alanna L.,Clark Robert J.,Santone Elizabeth A.,Kinsman Sarah,Xiao Deqing,Fox Lisa G.,Einolf Heidi J.,Stresser David M.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference43 articles.

1. Oxymorphone Extended Release Does Not Affect CYP2C9 or CYP3A4 Metabolic Pathways

2. Effect of itraconazole and terbinafine on the pharmacokinetics and pharmacodynamics of midazolam in healthy volunteers;Ahonen;Br J Clin Pharmacol,1995

3. Towards a Quantitative Framework for the Prediction of DDIs Arising from Cytochrome P450 Induction

4. Rifampin drastically reduces plasma concentrations and effects of oral midazolam

5. Concentrations and Effects of Oral Midazolam are Greatly Reduced in Patients Treated with Carbamazepine or Phenytoin

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applying Physiologically Based Pharmacokinetic Modeling to Interpret Carbamazepine’s Nonlinear Pharmacokinetics and Its Induction Potential on Cytochrome P450 3A4 and Cytochrome P450 2C9 Enzymes;Pharmaceutics;2024-05-30

2. Comprehensive Physiologically Based Pharmacokinetic Model to Assess Drug–Drug Interactions of Phenytoin;Pharmaceutics;2023-10-18

3. Regulatory Considerations in Metabolism‐ and Transport‐Based Drug Interactions;Oral Bioavailability and Drug Delivery;2023-10-10

4. Quantitative Cytochrome P450 3A4 Induction Risk Assessment Using Human Hepatocytes Complemented with Pregnane X Receptor-Activating Profiles;Drug Metabolism and Disposition;2022-12-02

5. Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models;European Journal of Drug Metabolism and Pharmacokinetics;2022-03-28